Golden State Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175K Buy
3,040
+4
+0.1% +$230 0.02% 439
2026
Q1
$184K Buy
3,036
+9
+0.3% +$525 0.02% 394
2025
Q4
$163K Sell
3,027
-483
-14% -$23.2K 0.02% 415
2025
Q3
$158K Sell
3,510
-9
-0.3% -$420 0.02% 421
2025
Q2
$163K Hold
3,519
0.02% 394
2025
Q1
$215K Hold
3,519
0.03% 327
2024
Q4
$199K Buy
+3,519
New +$197K 0.03% 323
2022
Q1
$215K Sell
2,942
-1,034
-26% -$69.4K 0.04% 285
2021
Q4
$248K Buy
+3,976
New +$233K 0.04% 321
2021
Q3
Sell
-3,181
Closed -$213K 310
2021
Q2
$213K Sell
3,181
-290
-8% -$18.9K 0.05% 275
2021
Q1
$219K Sell
3,471
-1,849
-35% -$115K 0.07% 188
2020
Q4
$330K Buy
5,320
+1,220
+30% +$75K 0.1% 166
2020
Q3
$247K Buy
+4,100
New +$247K 0.08% 168
2020
Q2
Sell
-3,281
Closed -$183K 277
2020
Q1
$183K Buy
+3,281
New +$201K 0.08% 167
2019
Q4
Sell
-2,598
Closed -$132K 155
2019
Q3
$132K Buy
2,598
+963
+59% +$45.3K 0.04% 272
2019
Q2
$74K Sell
1,635
-102
-6% -$4.75K 0.02% 383
2019
Q1
$83K Buy
+1,737
New +$86.5K 0.03% 351

Other funds holding BMY

Golden State Wealth Management's BMY Position: Q2 2026 in Review

Golden State Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.13% in Q2 2026, buying an estimated $230 and bringing the position to 3,040 shares worth $175K. The position accounts for 0.02% of the portfolio, ranked #439.

Golden State Wealth Management first reported a position in BMY in Q1 2019 and has held it in 17 quarters since. The position peaked at $330K in Q4 2020. 831 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Golden State Wealth Management held 3,040 shares of Bristol-Myers Squibb worth $175K as of Q2 2026.
  • Golden State Wealth Management bought 4 Bristol-Myers Squibb shares in Q2 2026, an estimated $230.
  • Bristol-Myers Squibb made up 0.02% of Golden State Wealth Management's portfolio in Q2 2026, its #439 holding.
  • Golden State Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 17 quarters since.
  • Golden State Wealth Management's Bristol-Myers Squibb position peaked at $330K in Q4 2020.
  • 831 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.